Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sanofi Genzyme

Sanofi Genzyme
1981 FOUNDED
PRIVATE STATUS
1K-5K EMPLOYEES
M&A LATEST DEAL TYPE
$20.1B LATEST DEAL AMOUNT
Description

Manufacturer of human health-care products. The company focuses on rare genetic disease disorders, renal diseases, orthopedics, cancers, transplant and immune diseases, and diagnostic and predictive testing areas. It operates as a biotechnology company worldwide.

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • 500 Kendall Street
  • Cambridge, MA 02142
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sanofi Genzyme’s full profile, request a free trial.

Sanofi Genzyme Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 08-Apr-2011 $20.1B 000.00 000.00 Completed Generating Revenue
2. IPO 05-Jun-1986 000.00 000.00 Completed Generating Revenue
1. Early Stage VC $10M $10M Completed
To view this company’s complete deal history including valuation and funding, request access »

Sanofi Genzyme Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Formerly VC-backed Cambridge, MA 0000 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Sanofi Genzyme Investments & Acquisitions (39)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 30-Apr-2015 00000 00000 00 0000 Drug Discovery
00000000 07-Jan-2015 0000 00000 00.000 Application Specific Semiconductors
000000 000000000 0 12-Jan-2012 00000 00000 00 000.00 Other Commercial Services
0000 00000 000 10-Jan-2012 00000 00000 00 00000 Drug Discovery
Zealand Pharma 23-Dec-2009 Later Stage VC 00000 Biotechnology
To view this company’s complete investment and acquisition history, request access »

Sanofi Genzyme Exits (10)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 30-Apr-2015 00000 00000 00 0000 Completed
  • 5 buyers
0000 00000 000 10-Jan-2012 00000 00000 00 00000 Completed
  • 3 buyers
0000000 000000 23-Dec-2009 00000 00000 00 00000 Completed
  • 3 buyers
00000 0000 0000000 08-Jul-2009 00000 00000 00 Completed
  • 5 buyers
TcLand Expression 14-Dec-2007 Early Stage VC 000.00 Completed
  • 4 buyers
To view this company’s complete exits history, request access »

Sanofi Genzyme Subsidiaries (7)

Company Name Industry Location Founded
ZyStor Therapeutics Biotechnology Wauwatosa, WI 2004
000000000 Drug Discovery Amsterdam, Netherlands 0000
00000000 000000000 Pharmaceuticals Princeton, NJ 0000
00000000000 Pharmaceuticals New York, NY 0000
000000 00000000 Biotechnology Bridgewater, NJ 0000
To view this company’s complete subsidiary history, request access »

Sanofi Genzyme Executive Team (32)

Name Title Board
Seat
Contact
Info
Philippe Sauvage Chief Financial Officer
Perla Halioua Chief of Staff to the EVP & Chief Strategy Officer
William Sibold Executive Vice President & Head
S├ębastien Martel Global Head of Rare Diseases
Robin Kenselaar Head of Europe

24 Former Executives

You’re viewing 5 of 32 executives. Get the full list »